Hypertension and dementia: Does blood pressure control favorably affect cognition?
- 68 Downloads
Dementia and aging are not synonymous. Dementia is a progressive deterioration in cognitive and social and/or occupational functions that can eventually impair a patient’s ability to live independently. Alzheimer’s disease is the most common form of dementia. It accounts for 50% to 70% of all patients with dementia. Vascular dementia, responsible for up to 15% of all diagnosed cases, is the second most common form of dementia. Hypertension remains a significant risk factor for vascular dementia. The optimal level of blood pressure control for the prevention of dementia and whether one particular class of antihypertensive drug is more beneficial than another remains uncertain.
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 2.Wentzel C, MacKnight C, Hachinski V, et al.: Cerebral white matter lesions and subjective cognitive dysfunction: the Rotterdam scan study. Neurology 2001, 56:1539–1545.Google Scholar
- 3.Pohjasraara T, Yliloski MA, Kaste M, et al.: Comparison of different clinical criteria (DSM-III, ADDTC, ICD-10, NINDS-AIREN, DSM-IV) for the diagnosis of vascular dementia. Stroke 2000, 31:2952–2957.Google Scholar
- 16.Ross GW, Petrovitch H, Masaki KH, et al.: The relation between mid-life blood pressure and dementia: the Honolulu Aging Study (abstract). Neurology 1998, 50:A229.Google Scholar
- 19.Lithell H, Hansson L, Skoog I, et al.: The study on cognition and prognosis in the elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens 2003, 21:875–886. In this study, candesartan was compared with placebo plus additional antihypertensive agents for reduction of cardiovascular events, cognitive decline, and dementia.PubMedCrossRefGoogle Scholar
- 20.SHEP Cooperative Group: Prevention of stroke by antihypertension drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991, 265:3255–3264. In this study, the effects of an active treatment group (low-dose diuretic and/or β-blocker) and placebo group on isolated systolic hypertension-related fatal/nonfatal stroke, myocardial infarction, fatal coronary disease, major cardiovascular morbidity and mortality, and cognitive decline were evaluated.CrossRefGoogle Scholar
- 22.Gurland B, Golden R, Challop J: Unidimensional and multidimensional approaches to the differential of depression and dementia in the elderly. In Alzheimer’s Disease: A Report of Progress in Research. Edited by Corkin S, Davis K, Crowden J. New York: Raven Press; 1981.Google Scholar
- 23.Weissman MM, Sholomskas D, Pottenger M, et al.: Assessing depression symptoms in five psychiatric populations: a validation study. Am J Epidemiol 1997, 106:203–214.Google Scholar
- 29.Fagard RH, Staessen JA: Treatment of isolated systolic hypertension in the elderly: the Syst-Eur trial. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Clin Exper Hypertens 1999, 21:491–497. This large scale, randomized trial evaluated participants with a history of previous stroke or TIA to determine the effect of blood pressure-lowering medications on the risks of dementia and cognitive decline.CrossRefGoogle Scholar
- 30.Forette F, Seux ML, Staessen JA, et al.: The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) Study. Arch Intern Med 2002, 162:2046–2052. Results of this trial showed that therapy with the calcium channel blocker nitrendipine decreased the incidence of dementia by 55%, suggesting that its prevention of dementia might be due to specific neuroprotection.PubMedCrossRefGoogle Scholar